Audet Juliette Berangere's Form 4 filing
NewAmsterdam Pharma Co N.V. (NAMS) · filed Sep 30, 2024
- Accession no.
- 0000950170-24-110440
- Filed
- Sep 30, 2024
- Trade date
- Sep 26, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $17.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Audet Juliette BerangereCIK 0002000393 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | Ordinary Shares | PPurchaseAcquired | +1,104 | $15.70 | +$17,332.8 | 1,104 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.